首页 | 本学科首页   官方微博 | 高级检索  
     


Potential Contribution of Preoperative Neoadjuvant Concurrent Chemoradiation Therapy on Margin-Negative Resection in Borderline Resectable Pancreatic Cancer
Authors:Chang Moo Kang  Yong Eun Chung  Jeong Youp Park  Ho Kyoung Hwang  Hye Jin Choi  Si Young Song  Woo Jung Lee
Affiliation:(1) Division of Hepatobiliary and Pancreas, Department of Surgery, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea;(2) Division of Gastroenterology, Yonsei University College of Medicine, Seoul, South Korea;(3) Department of Internal Medicine, Yonsei University College of Medicine, Seoul, South Korea;(4) Department of Radiologic Oncology, Yonsei University College of Medicine, Seoul, South Korea;(5) Department of Radiology, Yonsei University College of Medicine, Seoul, South Korea;(6) Division of Medical Oncology, Yonsei University College of Medicine, Seoul, South Korea;(7) Department of Pathology, Yonsei University College of Medicine, 50 Yonsei-ro, Seodaemun-gu, Seoul, 120-752, South Korea;(8) Pancreaticobiliary Cancer Clinic, Institute of Gastroenterology, Yonsei University Health System, Seoul, South Korea;(9) Young Yonsei Panceatic Tumor Study Group, Seoul, South Korea;
Abstract:

Background  

Margin-negative pancreatectomy provides only chance to cure pancreatic cancer. However, borderline resectable pancreatic cancer (BRPCa) has the risk of incomplete palliative resection.
Keywords:
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号